164 related articles for article (PubMed ID: 24935337)
1. Supplementing mesenchymal stem cells improves the therapeutic effect of hematopoietic stem cell transplantation in the treatment of murine systemic lupus erythematosus.
Liu RH; Li YQ; Zhou WJ; Shi YJ; Ni L; Liu GX
Transplant Proc; 2014 Jun; 46(5):1621-7. PubMed ID: 24935337
[TBL] [Abstract][Full Text] [Related]
2. [Combined mesenchymal stem cells and allogenic bone marrow transplantation in treatment of MRL/lpr mice].
Zhang GF; Zhang X; Dong GF
Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):754-7. PubMed ID: 19080203
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.
Gu Z; Akiyama K; Ma X; Zhang H; Feng X; Yao G; Hou Y; Lu L; Gilkeson GS; Silver RM; Zeng X; Shi S; Sun L
Lupus; 2010 Nov; 19(13):1502-14. PubMed ID: 20647254
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
[TBL] [Abstract][Full Text] [Related]
6. Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice.
Kim DH; Yoo KH; Yim YS; Choi J; Lee SH; Jung HL; Sung KW; Yang SE; Oh WI; Yang YS; Kim SH; Choi SY; Koo HH
J Korean Med Sci; 2006 Dec; 21(6):1000-4. PubMed ID: 17179676
[TBL] [Abstract][Full Text] [Related]
7. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model.
Fernández-García M; Yañez RM; Sánchez-Domínguez R; Hernando-Rodriguez M; Peces-Barba M; Herrera G; O'Connor JE; Segovia JC; Bueren JA; Lamana ML
Stem Cell Res Ther; 2015 Sep; 6(1):165. PubMed ID: 26345192
[TBL] [Abstract][Full Text] [Related]
9. Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.
Xu J; Chen J; Li W; Lian W; Huang J; Lai B; Li L; Huang Z
J Am Soc Nephrol; 2020 Jan; 31(1):54-65. PubMed ID: 31604808
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.
Sui W; Hou X; Che W; Chen J; Ou M; Xue W; Dai Y
Clin Immunol; 2013 Aug; 148(2):186-97. PubMed ID: 23770628
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
Cheng T; Ding S; Liu S; Li Y; Sun L
Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511
[No Abstract] [Full Text] [Related]
12. High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F-actin cytoskeleton in systemic lupus erythematosus.
Shi D; Li X; Chen H; Che N; Zhou S; Lu Z; Shi S; Sun L
Pathol Biol (Paris); 2014 Dec; 62(6):382-90. PubMed ID: 25239279
[TBL] [Abstract][Full Text] [Related]
13. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice.
Mai S; Zou L; Tian X; Liao X; Luan Y; Han X; Wei Y; Wu Y; Kuang S; Yang Y; Ma J; Chen Q; Yang J
Mol Pharm; 2018 May; 15(5):1800-1813. PubMed ID: 29668284
[TBL] [Abstract][Full Text] [Related]
14. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation.
Yuan L; Xiao ZT; Huang XZ; Wu MJ; Shi H; Liu AF
Ren Fail; 2016 Oct; 38(9):1432-1440. PubMed ID: 27416851
[TBL] [Abstract][Full Text] [Related]
15. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
16. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
[TBL] [Abstract][Full Text] [Related]
17. Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.
Lee HK; Kim HS; Pyo M; Park EJ; Jang S; Jun HW; Lee TY; Kim KS; Bae SC; Kim Y; Hong JT; Yun J; Han SB
Theranostics; 2020; 10(22):10186-10199. PubMed ID: 32929342
[No Abstract] [Full Text] [Related]
18. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation.
Ma X; Che N; Gu Z; Huang J; Wang D; Liang J; Hou Y; Gilkeson G; Lu L; Sun L
Cell Transplant; 2013; 22(12):2279-90. PubMed ID: 23127285
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells promote CD206 expression and phagocytic activity of macrophages through IL-6 in systemic lupus erythematosus.
Deng W; Chen W; Zhang Z; Huang S; Kong W; Sun Y; Tang X; Yao G; Feng X; Chen W; Sun L
Clin Immunol; 2015 Dec; 161(2):209-16. PubMed ID: 26209923
[TBL] [Abstract][Full Text] [Related]
20. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
